Antibodies, Antineutrophil Cytoplasmic [protilátky proti cytoplazmě neutrofilů]
- Terms
-
ANCA
anti-neutrofilní cytoplazmatické autoprotilátky
antineutrofilní cytoplazmatické autoprotilátky
autoprotilátky proti cytoplazmě neutrofilů
c-ANCA
p-ANCA
protilátky ANCA
protilátky proti cytoplazmě neutrofilních leukocytů
-
ANCA
Anti-Neutrophil Cytoplasmic Antibodies
Anti-Neutrophil Cytoplasmic Antibody
Anti-Neutrophil Cytoplasmic Autoantibodies
Anti-Neutrophil Cytoplasmic Autoantibody
Antineutrophil Cytoplasmic Antibodies
Antineutrophil Cytoplasmic Antibody
c-ANCA
Neutrophil Cytoplasmic Autoantibodies
Neutrophil Cytoplasmic Autoantibody
p-ANCA
Autoantibodies directed against cytoplasmic constituents of POLYMORPHONUCLEAR LEUKOCYTES and/or MONOCYTES. They are used as specific markers for GRANULOMATOSIS WITH POLYANGIITIS and other diseases, though their pathophysiological role is not clear. ANCA are routinely detected by indirect immunofluorescence with three different patterns: c-ANCA (cytoplasmic), p-ANCA (perinuclear), and atypical ANCA.
- Annotation
- do not coordinate with ANTIBODY FORMATION for /biosyn;
- DUI
- D019268 MeSH Browser
- CUI
- M0028696
- Previous indexing
- Autoantibodies (1991-1996)
- History note
- 97; was C-ANCA (NM) 1991-96
- Online note
- use ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC (NM) to search C-ANCA 1991-96
- Public note
- 97; C-ANCA was indexed under AUTOANTIBODIES 1991-96
Allowable subheadings
- AD
- administration & dosage
- AE
- adverse effects 5
- AN
- analysis 16
- BI
- biosynthesis 1
- BL
- blood 43
- CF
- cerebrospinal fluid
- CH
- chemistry
- CL
- classification
- DE
- drug effects
- EC
- economics
- GE
- genetics
- HI
- history
- IM
- immunology 27
- IP
- isolation & purification
- ME
- metabolism 4
- PD
- pharmacology 1
- PH
- physiology 2
- PO
- poisoning
- RE
- radiation effects
- TU
- therapeutic use
- TO
- toxicity
- UL
- ultrastructure
- UR
- urine 1
anti-glomerular basement membrane autoantibody Chemical MeSH Browser
anti-myeloperoxidase autoantibody Chemical MeSH Browser